An Albumin-Free Formulation for Escherichia coli-Derived Interferon Beta-1b with Decreased Immunogenicity in Immune Tolerant Mice

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
Mohadeseh Haji AbdolvahabHuub Schellekens

Abstract

Human serum albumin (HSA)-free formulation of Escherichia coli-derived human interferon beta (IFNβ-1b) with a high percentage of monomeric protein and low immunogenicity is developed and characterized in the current study. UV spectroscopy, fluorescence spectroscopy, dynamic light scattering, sodium dodecyl sulfate polyacrylamide gel electrophoresis, Western blotting, Micro-Flow Imaging, resonant mass measurement, size exclusion, and reversed-phase high performance liquid chromatographies were applied to assess the effect of excipients on the stability of IFNβ-1b to establish a HSA-free formulation. The antiviral activity of IFNβ-1b was evaluated using human lung carcinoma cell line. Immune tolerant mice to hIFNβ were used to assess the immunogenicity of the HSA-free formulated IFNβ-1b in comparison to Betaferon drug product and Avonex drug substance as standards through IgG titering of plasma. HSA-free formulated IFNβ-1b, including 200 mM L-arginine, 200 mM trehalose, and 0.1% n-dodecyl β-D-maltoside in 10 mM sodium acetate buffer, pH 7.4, showed the highest biological activity. The stability of IFNβ-1b in the HSA-free formulation was monitored for 3 weeks at 4°C and 37°C with relative humidity of 10% and 75%, respectively. Pro...Continue Reading

References

Apr 1, 1990·Journal of Interferon Research·M BoublikH F Kung
Aug 1, 1988·Journal of Interferon Research·J GeigertM Pemberton
Oct 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·M KarpusasS Goelz
Jul 17, 1998·Biochemistry·Y Chen, M D Barkley
Dec 16, 1998·Cellular and Molecular Life Sciences : CMLS·M KarpusasP Hochman
Aug 26, 1999·International Journal of Pharmaceutics·W Wang
Oct 25, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·G GiovannoniF Deisenhammer
Nov 27, 2002·Neurology·M ClanetUNKNOWN European IFNbeta-1a (Avonex) Dose-Comparison Study Investigators
Apr 2, 2005·Nature Reviews. Drug Discovery·Sven Frokjaer, Daniel E Otzen
May 17, 2005·Protein Expression and Purification·Matsujiro IshibashiTsutomu Arakawa
Jun 11, 2005·Pharmaceutical Research·Suzanne HermelingHuub Schellekens
Jul 30, 2005·Journal of Pharmaceutical Sciences·Haihong FanC Russell Middaugh
Apr 27, 2007·Nature·Thomas P BurgScott R Manalis
Jun 19, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Andrea Hawe, Wolfgang Friess
Sep 6, 2007·Journal of Pharmaceutical Sciences·Andrea Hawe, Wolfgang Friess
May 29, 2008·Multiple Sclerosis : Clinical and Laboratory Research·P S SorensenK Bendtzen
Jul 3, 2008·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·C LallemandM G Tovey
Jan 9, 2009·Bioscience, Biotechnology, and Biochemistry·Hyun-Jung KimChan-Wha Kim
Apr 29, 2009·Current Opinion in Rheumatology·Gerrit J WolbinkB A C Dijkmans
Jun 13, 2009·Current Pharmaceutical Biotechnology·John S Philo
Oct 28, 2009·Journal of Immunological Methods·Miranda M C van BeersWim Jiskoot
Jun 10, 2010·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Robert A RifkinMichael Levy
Sep 30, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Miranda M C van BeersHuub Schellekens
Sep 1, 2008·Therapeutic Advances in Neurological Disorders·Per Soelberg Sorensen
Jul 16, 2011·Advanced Drug Delivery Reviews·Satoshi OhtakeTsutomu Arakawa
Sep 16, 2011·Journal of Pharmaceutical Sciences·Miranda M C Van BeersWim Jiskoot
Nov 28, 2012·Journal of Biotechnology·Ahmad FazeliAli Akbar Moosavi-Movahedi
Jan 31, 2013·Pharmaceutical Research·Grzegorz KijankaVera Brinks
Jun 24, 2014·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Mohadeseh Haji AbdolvahabHuub Schellekens
Aug 22, 2014·AAPS PharmSciTech·Ahmad FazeliMohammad Reza Fazeli
Dec 3, 2014·Journal of Immunological Methods·Mohadeseh Haji AbdolvahabHuub Schellekens

❮ Previous
Next ❯

Citations

Sep 7, 2017·Scientific Reports·Lydia Asrat HaileDaniela Verthelyi
Jan 18, 2020·Bioconjugate Chemistry·Shayan AbbasiShahriar Pooyan

❮ Previous
Next ❯

Methods Mentioned

BETA
deamidation
dynamic light scattering
electrophoresis
Fluorescence
Biosensors
transgenic
enzyme-linked immunosorbent assay
Light scattering
ELISA

Software Mentioned

GraphPad
Particle Lab
Empower
MFI View System Software ( MVSS )
Quantity One
ProteinSimple
MVAS
GraphPad Prism
ALV Correlator

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.